SG11201400243PA - Methods and compositions for determining smoking status - Google Patents

Methods and compositions for determining smoking status

Info

Publication number
SG11201400243PA
SG11201400243PA SG11201400243PA SG11201400243PA SG11201400243PA SG 11201400243P A SG11201400243P A SG 11201400243PA SG 11201400243P A SG11201400243P A SG 11201400243PA SG 11201400243P A SG11201400243P A SG 11201400243PA SG 11201400243P A SG11201400243P A SG 11201400243PA
Authority
SG
Singapore
Prior art keywords
compositions
methods
smoking status
determining smoking
determining
Prior art date
Application number
SG11201400243PA
Other languages
English (en)
Inventor
Steven Rosenberg
Michael Reid Elashoff
Philip Beineke
James A Wingrove
Original Assignee
Cardiodx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cardiodx Inc filed Critical Cardiodx Inc
Publication of SG11201400243PA publication Critical patent/SG11201400243PA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Data Mining & Analysis (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Primary Health Care (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioethics (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Evolutionary Computation (AREA)
  • Software Systems (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG11201400243PA 2011-08-29 2012-08-24 Methods and compositions for determining smoking status SG11201400243PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161528616P 2011-08-29 2011-08-29
PCT/US2012/052303 WO2013032917A2 (fr) 2011-08-29 2012-08-24 Procédés et compositions pour la détermination du statut de fumeur

Publications (1)

Publication Number Publication Date
SG11201400243PA true SG11201400243PA (en) 2014-03-28

Family

ID=47757128

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201400243PA SG11201400243PA (en) 2011-08-29 2012-08-24 Methods and compositions for determining smoking status

Country Status (12)

Country Link
US (2) US20150178462A1 (fr)
EP (1) EP2751290A4 (fr)
JP (1) JP2014531202A (fr)
KR (1) KR20140051461A (fr)
CN (1) CN103890193A (fr)
AU (1) AU2012300375A1 (fr)
BR (1) BR112014004768A2 (fr)
CA (1) CA2846837A1 (fr)
EA (1) EA201490533A1 (fr)
IL (1) IL231131A0 (fr)
SG (1) SG11201400243PA (fr)
WO (1) WO2013032917A2 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103389376B (zh) * 2013-08-21 2015-08-19 中南大学湘雅医院 评估肝细胞癌临床分期和预后的试剂盒及ecscr的应用
JP6703479B2 (ja) * 2013-12-16 2020-06-03 フィリップ モリス プロダクツ エス アー 個人の喫煙ステータスを予測するためのシステムおよび方法
CN105214077B (zh) * 2014-06-03 2019-02-05 浙江阿思科力生物科技有限公司 Usp33在肿瘤中的应用
CN114807368A (zh) * 2014-07-14 2022-07-29 威拉赛特公司 用于评估肺癌状态的方法
CN104651354B (zh) * 2015-01-21 2017-12-15 田小利 Scml4基因序列及表达改变检测及其在冠心病预测中的应用
EP3250609A4 (fr) * 2015-01-26 2018-07-11 The University of Chicago Agents de liaison à l'il13ra alpha 2 et leur utilisation dans le traitement du cancer
CN105296658A (zh) * 2015-11-30 2016-02-03 北京泱深生物信息技术有限公司 Alkbh2基因在缺血性脑卒中诊断中的应用
EP3475911A1 (fr) * 2016-06-22 2019-05-01 Swiss Reinsurance Company Ltd. Système d'assurance-vie à processus de souscription entièrement automatisé pour une souscription et un réglage du risque en temps réel, et son procédé correspondant
BR112019004920A2 (pt) * 2016-09-14 2019-06-04 Philip Morris Products Sa sistemas, métodos e assinaturas de genes para prever um status biológico de um indivíduo
CN106801095A (zh) * 2017-02-14 2017-06-06 徐州市中心医院 Prrt1基因在制备冠心病诊断产品中的应用
CN107937521B (zh) * 2017-11-19 2019-01-04 武汉迈特维尔生物科技有限公司 用于检测肾上腺皮质癌的试剂盒
CN108611413B (zh) * 2018-03-30 2021-10-01 青岛泱深生物医药有限公司 一种帕金森相关生物标志物及其应用
CN108070649A (zh) * 2018-02-07 2018-05-25 北京泱深生物信息技术有限公司 Kcne1基因在诊断慢性阻塞性肺疾病中的应用
CN108303547A (zh) * 2018-02-07 2018-07-20 北京泱深生物信息技术有限公司 一种用于诊断慢性阻塞性肺疾病的分子标志物
RU2690393C1 (ru) * 2018-05-29 2019-06-04 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт комплексных проблем гигиены и профессиональных заболеваний" Способ прогнозирования вероятности развития атеросклероза у шахтеров с хроническим пылевым бронхитом
CN109055522A (zh) * 2018-07-03 2018-12-21 吉林大学 C4orf38在制备用于检测或治疗神经性疼痛的产品中的应用
CN111500733B (zh) * 2020-05-27 2022-03-08 中国人民解放军军事科学院军事医学研究院 外周血单核细胞中用于非小细胞肺癌早期诊断的分子标记物
CN111856031B (zh) * 2020-07-21 2023-04-28 国家烟草质量监督检验中心 通过测定外周血中性粒细胞中蛋白的表达来鉴定烟碱暴露的潜在生物标志物的方法
CN114231529B (zh) * 2021-11-17 2023-08-01 中国科学院昆明动物研究所 一种人pkmyt1ar基因及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7102429B2 (en) * 2002-06-28 2006-09-05 Motorola, Inc. RF amplifier with enhanced efficiency
CA2528669A1 (fr) * 2003-06-09 2005-01-20 The Regents Of The University Of Michigan Compositions et methodes de traitement et de diagnostic du cancer
CN1852974A (zh) * 2003-06-09 2006-10-25 密歇根大学董事会 用于治疗和诊断癌症的组合物和方法
DE102004003612B4 (de) * 2004-01-25 2015-01-08 grapho metronic Meß- und Regeltechnik GmbH Verfahren und Auswertung eines Bildes von einem vorbestimmten Ausschnitt eines Druckerzeugnisses
CA2645310A1 (fr) * 2006-03-09 2007-09-13 The Trustees Of Boston University Methodes de diagnostic et de pronostic pour troubles des poumons utilisant des profils d'expression de genes de cellules epitheliales nasales
WO2008063521A2 (fr) * 2006-11-13 2008-05-29 The General Hospital Corporation Système d'évaluation clinique basé sur des gènes
WO2008109773A2 (fr) * 2007-03-06 2008-09-12 Cornell Research Foundation, Inc. Prédisposition aux maladies pulmonaires obstructives chroniques, compositions et procédés associés
US8825587B2 (en) * 2009-04-14 2014-09-02 Cardiodx, Inc. Predictive models and method for assessing age

Also Published As

Publication number Publication date
CN103890193A (zh) 2014-06-25
WO2013032917A2 (fr) 2013-03-07
JP2014531202A (ja) 2014-11-27
US20190311808A1 (en) 2019-10-10
BR112014004768A2 (pt) 2019-09-24
EP2751290A4 (fr) 2015-07-15
IL231131A0 (en) 2014-03-31
WO2013032917A3 (fr) 2013-06-13
CA2846837A1 (fr) 2013-03-07
US20150178462A1 (en) 2015-06-25
EA201490533A1 (ru) 2014-08-29
KR20140051461A (ko) 2014-04-30
EP2751290A2 (fr) 2014-07-09
AU2012300375A1 (en) 2014-03-20

Similar Documents

Publication Publication Date Title
IL231131A0 (en) Methods and preparations for determining smoking status
EP2742154A4 (fr) Compositions de biomarqueurs et procédés
EP2721179A4 (fr) Compositions de biomarqueur et procédés associés
HK1199911A1 (en) Compositions and methods for toxigenicity testing
EP2731446A4 (fr) Procédés et compositions pour produits consommables
PL2731451T3 (pl) Sposoby i kompozycje dla produktów żywnościowych
HK1202625A1 (en) Compositions and methods for assessing appendicitis
EP2740370A4 (fr) Cigarette
ZA201306316B (en) Methods and compositions for preparing noribogaine from voacangine
EP2691397A4 (fr) Procédés et compositions pour la préparation de noribogaïne à partir de voacangine
HK1201469A1 (en) Compositions and methods for hemostasis
ZA201307187B (en) Synergistic compositions and methods
PL2785823T3 (pl) Kompozycje i sposoby do czyszczenia
EP2692252A4 (fr) Cigarette
IL227924B (en) Preparations and methods of use for determining a4he
EP2785176A4 (fr) Compositions antimicrobiennes et procédés correspondants
GB201411762D0 (en) Precoating methods and compositions
IL250307A0 (en) Pesticide preparations and methods
EP2734646A4 (fr) Compositions et procédés pour sélectionner des aptamères
ZA201308892B (en) Compositions and methods
EP2766357A4 (fr) Compositions méso-biliverdines et procédés associés
EP2798327A4 (fr) Compositions et procédés de préparation d'échantillons
IL230868A0 (en) Biomarker preparations and methods
GB201116340D0 (en) Compositions and methods
IL228723B (en) Synergistic compositions and methods